Joel Richardson is a New York York Times bestselling author, internationally recognized teacher, artist, and craftsman. His work has been featured on numerous radio, television, and news outlets.
Thank you for coming to this channel. I hope that you enjoy each video update, learn more about what God is doing in our world, and share what you learn with others. Blessings!
These Dinosaurs Looked WAY Different Than How They Portray Them - YouTube
The new Jurassic World: Rebirth movie just came out. It depicts many different dinosaurs, but just how accurate are they? In this video, Joel Leineweber shar...
Why You Are TIRED All The Time | Dr. Andy Galpin - YouTube
Want better sleep, faster recovery, and peak performance? In this powerful episode of The Dr. Hyman Show, Dr. Mark Hyman sits down with human performance exp...
The Road to Armageddon Iran's Nuclear Showdown - YouTube
This short video was created in May of 2024. The things Gary Stearman and Bill Salus discussed concerning the current events in Iran at that time, we are sti...
The Parkinson’s Pandemic And How We Can Stop It | Interview with Dr. Michael Okun - YouTube
#Parkinsons #TheParkinsonsPlan #EnvironmentalHealth #Neuroscience #PreventParkinsonsParkinson’s disease is rising faster than ever before — with 90,000 new U...
Low molecular weight fucoidan: Production methods and their therapeutic applications - ScienceDirect
Low molecular weight fucoidan (LMWF), a depolymerized form, is known to possess superior bioactivities compared to its high molecular weight counterpa…
Link to the notes: https://docs.google.com/document/d/1G0JYEOi1HyTzyT3RxAX8AbIZejyZyl_s/edit?usp=drivesdk&ouid=102430545303799711405&rtpof=true&sd=true C04-5-18
Who Changed the Bible in Genesis 5 and 11? - YouTube
Henry B. Smith Jr. of Associates for Biblical Research is the guest on Let Us Reason and discusses the numerical divergences between the Masoretic Text, Sama...
Frontiers | Fucoidan as a Therapeutic Agent for Ulcerative Colitis: Mechanisms of Action and Modulation of the Gut Microbiota
Ulcerative colitis (UC), a chronic inflammatory bowel disease driven by gut dysbiosis, immune dysregulation, and oxidative stress, lacks universally effectiv...
Anti-lung cancer activities of polysaccharides from Laminaria japonica: Network pharmacology and structural insights - ScienceDirect
This study investigates the anti-lung cancer activities of polysaccharides extracted from Laminaria japonica, focusing on their bioactive components a…
The Prophecy of Elam (Iran) is it Happening Now? - YouTube
About 2600 years ago, the prophet Jeremiah predicted that in the latter days a disaster would happen in ELAM, which is in modern day SW IRAN. The details of ...
Jewish Temple Plans ACCELERATING Biblical End Times Events NOW - YouTube
Israel is at the center of the End Times. So Jewish End Time beliefs influence what happens NEXT. And they are NOT what you EXPECT. They will impact how Jew...
Ezekiel 38, Is it NEXT? Hughes & Salus Discussion - YouTube
Ezekiel 38 is a marquee prophetic event of the end times. Many of today's top experts think it could be the next prophecy to find fulfillment. But are they c...
Intranasal Delivery of Ivermectin Nanosystems as an Antitumor Agent: Focusing on Glioma Suppression | ACS Biomaterials Science & Engineering
Glioblastoma presents significant challenges in neuro-oncology due to its aggressive nature, drug resistance, and restrictions imposed by the blood–brain barrier. Ivermectin (IVM), known for its antiparasitic properties, has been highlighted as a promising treatment for tumors and an alternative therapy for glioma, although it exhibits low oral bioavailability. Therefore, we investigated the in vivo effect of IVM encapsulation in organic and inorganic nanosystems, first screened in vitro against different tumor cells and subsequently evaluated in vitro and in vivo glioma models. We produced IVM-loaded poly(ε-caprolactone) nanocapsules (IVM-NC) using the interfacial deposition method, and IVM-loaded nanostructured silica particles (IVM-MCM) by loading IVM into commercial MCM-41 silica using the incipient wetness method. IVM-NC had a nanometric size (190 nm), a unimodal size distribution (span <2), and a high encapsulation efficiency (100% at 1 mg/mL). IVM-MCM exhibited a well-organized hexagonal mesoporous structure and high drug loading (0.12 mg/mg). Nanoencapsulated IVM significantly reduced the viability of various cancer cell lines, particularly glioma cell lines, which led us to evaluate them in a preclinical glioma model. We implanted adult male Wistar rats with C6 cells. Intranasal delivery of IVM-NC (60 μg/rat/day for 10 days) resulted in a larger decrease in tumor size compared with the group treated with free IVM, along with histopathological improvements. Treatment with IVM-MCM did not decrease the tumor size. However, both treatments were well-tolerated, with no adverse effects on weight, biochemical, or hematological parameters, or lung histology. Furthermore, the effective equivalent dose of IVM (26 μg/kg) in the rat glioma model was lower than the approved human dose for parasitic infections. This study marks the first exploration of IVM delivery to the brain. In summary, nasal administration of nanoencapsulated IVM via nanocapsules presents a promising avenue for targeted therapy against glioblastoma, with potential implications for clinical translation.
Targeting the Mitochondrial-Stem Cell Connection in Cancer Treatment: A Hybrid Orthomolecular Protocol - ISOM
.
Introduction
Many theories exist regarding the origin of cancer, namely the metabolic theory (Seyfried & Chinopoulos, 2021), the somatic mutation theory (SMT) (Hanahan & Weinberg, 2000), the cancer stem cell theory (Capp, 2019), and the tissue organization theory (Soto & Sonnenschein, 2011). In a recently published study, a new concept was introduced the
Unlock Your Body's Healing Power: A Detoxification Guide - YouTube
In this video, Dr. Nathan Bryan explains a detoxification protocol designed to target chronic diseases driven by nutrient deficiencies and toxin exposure. Th...
Share This
Sign up at: ParkinsonsDisease.blog
About Jonathan Sackner-Bernstein, MD
Dr. Sackner-Bernstein shares his pursuit of conquering Parkinson's, using expertise developed as Columbia University faculty, FDA senior official, DARPA insider and witness to the toll of PD.
Dr. S-B’s Linkedin page
RightBrainBio, Inc. was incorporated in 2022 to develop tranformative therapies for people with Parkinson's.
Dwayne Johnson on Health, Fatherhood, and Taking a Closer Look - YouTube
Dwayne “The Rock” Johnson discusses his health journey —and the test results that pushed him to take more control of his health.In this powerful episode of T...
Ron Wyatt's discovery of Sodom and Gomorrah is miraculous- the evidence was hidden until just the right time! the remains are spectacular to view and the mes...